ngµç×ÓÓÎÏ·

05

¿ÆÑÐÏ£Íû

³ÂÑǾü½ÌÊÚÍŶӽÒÏþÈ«Çò¶ùͯÇàÉÙÄê½üÊÓ»¼²¡ÂÊ¡¢¡¢¡¢×ª±äÇ÷ÊÆ¼°Î´À´¿ªÕ¹Ô¤²âµÄ×îÐÂЧ¹û

¸å¼þȪԴ£º¹«¹²ÎÀÉúѧԺ ±à¼­£ºÎâÁ¢¼á ÉóºË£ºËïÒ«±ó ÔĶÁÁ¿£º

ngµç×ÓÓÎÏ·ÐÂÎÅÍøÑ¶£¨Í¨Ñ¶Ô±ÆÕÓ­çù¡¢¡¢¡¢³Â¼Ñçù¡¢¡¢¡¢Áº¾°ºê£©¿ËÈÕ£¬ £¬ngµç×ÓÓÎÏ·¹«¹²ÎÀÉúѧԺ³ÂÑǾü½ÌÊÚÍŶӵÄÒ»ÏîÑо¿ÏÔʾ£¬ £¬È«ÇòԼĪÿÈýÃû¶ùͯÇàÉÙÄêÖоÍÓÐÒ»ÈË»¼ÓнüÊÓ£¬ £¬Ô¤¼Æµ½2050Ä꣬ £¬ÕâÒ»ÄêËê¶ÎµÄ½üÊÓ»¼²¡ÈËÊý½«Áè¼Ý7.4ÒÚÀý¡£¡£¸ÃÑо¿×ÛºÏÁË1990ÄêÖÁ2023Äê¼ä£¬ £¬È«Çò50¶à¸ö¹ú¼Ò¡¢¡¢¡¢276ÏîÑо¿¡¢¡¢¡¢540¶àÍòÃû¶ùͯÇàÉÙÄêµÄÊý¾Ý£¬ £¬Í¬Ê±Í¨¹ýʱ¼äÐòÁÐÄ£×Ó׼ȷԤ²âÁËδÀ´30Äê¶ùͯÇàÉÙÄê½üÊÓ»¼²¡ÂʵÄ×ßÊÆ¡£¡£¸ÃÑо¿Õ¹ÏÖÁËÈ«Çò½üÊÓÎÊÌâµÄÑÏËàÏÖ×´ºÍδÀ´¿ªÕ¹Ç÷ÊÆ£¬ £¬Îª¹«¹²ÎÀÉú¾öÒéÌṩÁËÖ÷ÒªÒÀ¾Ý¡£¡£Ïà¹ØÐ§¹ûÒÔ¡°Global Prevalence, Trend and Projection of Myopia in Children and Adolescents from 1990 to 2050: A Comprehensive Systematic Review and Meta-analysis¡±ÎªÌâ½ÒÏþÔÚÑÛ¿ÆÁìÓòȨÍþÆÚ¿¯¡¶Ó¢¹úÑÛ¿ÆÑ§ÔÓÖ¾¡·¡£¡£

DC5494135EBF731DCBF10F968FB_BAB14BB6_26436

ͼÐÎÕªÒª

Ä¿½ñ£¬ £¬½üÊÓÒѳÉΪȫÇò¹«¹²ÎÀÉúµÄÖØ´óÌôÕ½Ö®Ò»£¬ £¬Æä»¼²¡ÂÊÔÚ¶ùͯÇàÉÙÄêȺÌåÖÐѸËÙÅÊÉý¡£¡£Ñо¿ÍŶӲο¼ÁË×èÖ¹2023Äê6ÔµÄ45,470ƪÏà¹ØÑо¿ºÍÕþ¸®±¨¸æ£¬ £¬»ùÓÚÑÏ¿áµÄÄÉÅűê×¼ºÍÖÊÁ¿ÆÀ¹À£¬ £¬×îºóÄÉÈëÁýÕÖÀ´×ÔÑÇÖÞ¡¢¡¢¡¢Å·ÖÞ¡¢¡¢¡¢·ÇÖÞ¡¢¡¢¡¢´óÑóÖÞ¡¢¡¢¡¢±±ÃÀºÍÀ­¶¡ÃÀÖÞ50¸ö¹ú¼ÒµÄ276ÏîÑо¿£¬ £¬5,410,945Ãû¶ùͯÇàÉÙÄ꣬ £¬Éæ¼°1,969,090Ãû½üÊÓ²¡Àý¡£¡£Ñо¿ÍŶÓÕûºÏÁËËùÓÐÕâЩÑо¿Êý¾Ý£¬ £¬²¢Ë¼Á¿Á˵ØÀí¡¢¡¢¡¢Ê±¼äÒÔ¼°ÆäËü±äÁ¿£¬ £¬Ê¹ÓÃËæ»úЧӦģ×ÓÔ¤¼Æ½üÊÓµÄ×ÜÌåÊ¢ÐÐÂʼ°Æäʱ¼äÇ÷ÊÆ£¬ £¬½ÓÄÉ×Իعé»ý·Ö»¬¶¯Æ½¾ùÄ£×ÓÔ¤²â2050ÄêÈ«Çò¶ùͯÇàÉÙÄê½üÊÓÊ¢ÐÐÂÊ£¬ £¬²¢Í¨¹ýµ÷½â©¶·Í¼ºÍEggerÄ¥Á·ÆÀ¹À½ÒÏþÆ«ÒС£¡£

Ñо¿ÏÔʾ£¬ £¬È«Çò¶ùͯÇàÉÙÄê½üÊÓ»¼²¡ÂʵÄÔ¤¼ÆÖµÎª30.5%£¬ £¬²¢ÇÒÔÚÒÑÍù30Äê¼äÏÔÖøÔöÌí£¬ £¬´ÓÔ¼ËÄ·ÖÖ®Ò»ÔöÌíµ½ÏÖÔÚµÄÈý·ÖÖ®Ò»£º1990-2000ÄêÈ«Çò¶ùͯÇàÉÙÄê½üÊÓ»¼²¡ÂÊΪ24.3%£»£»2001-2010ÄêΪ25.3%£»£»2011-2019ÄêÔöÌíÖÁ29.7%£»£»2020-2023Äêʱ´ú£¬ £¬½üÊÓÂʸüÊǼ±¾çÅÊÉý£¬ £¬ÆäÖÐÇàÉÙÄêµÄ½üÊÓÂʸߴï54%¡£¡£

¾­¼Ã¿ªÕ¹Ë®Æ½¶Ô½üÊÓ»¼²¡ÂÊÓÐÏÔÖøÓ°Ï죬 £¬¿ªÕ¹Öйú¼Ò»ò²»Å¹ú¼ÒµÄ½üÊÓ»¼²¡ÂÊ£¨31.9%£©ÏÔןßÓÚÅ¹ú¼Ò£¨23.8%£©¡£¡£ÆäÖУ¬ £¬ÑÇÖÞµØÇøµÄ½üÊÓ»¼²¡ÂÊ×î¸ß£¬ £¬µÖ´ï35.2%£»£»À­¶¡ÃÀÖ޺ͼÓÀձȵØÇø×îµÍ£¬ £¬½öΪ3.8%¡£¡£ÔÚ±¾Ñо¿°üÀ¨µÄ50¸ö¹ú¼ÒÖУ¨Í¼2£©£¬ £¬ÈÕ±¾µÄ¶ùͯÇàÉÙÄê½üÊÓ»¼²¡ÂÊ×î¸ß£¨86.0%£©£¬ £¬Æä´ÎÊǺ«¹ú£¨73.9%£©¡¢¡¢¡¢¶íÂÞ˹£¨46.2%£©ºÍÐÂ¼ÓÆÂ£¨44.1%£©£»£»ÖйúÅÅÔÚµÚÎå룬 £¬Îª41.1%¡£¡£

½üÊÓ»¼²¡ÂÊÔÚÄêËê¡¢¡¢¡¢ÐÔ±ðºÍµØÇø·½Ãæ²î±ðÒ²ºÜÊÇÏÔ×Å¡£¡£ÕûÌå¶øÑÔ£¬ £¬ÇàÉÙÄêµÄ½üÊÓ»¼²¡ÂʸßÓÚ¶ùͯ£¬ £¬Ðè×¢ÖØµÄÊÇ£¬ £¬´Ó1990Äêµ½2023Ä꣬ £¬¶ùͯ½üÊÓ»¼²¡Âʵľø¶ÔÔöÌíÂÊԼΪÇàÉÙÄêµÄÁ½±¶¡£¡£ÐÔ±ð·½Ã棬 £¬Å®º¢µÄ½üÊÓ»¼²¡ÂÊ£¨33.6%£©ÂÔ¸ßÓÚÄк¢£¨30.5%£©£¬ £¬ÆäÖÐÇà´ºÆÚÅ®º¢µÄ½üÊÓ»¼²¡Âʵִï48.8%£»£»ÑÇÖÞÅ®º¢µÄ½üÊÓ»¼²¡ÂÊ£¨37.7%£©¸ßÓÚÑÇÖÞÄк¢£¨34.3%£©£¬ £¬Æä´ÎÊDZ±ÃÀÖÞÅ®º¢£¨26.9%£©ºÍ±±ÃÀÖÞÄк¢£¨24.1%£©¡£¡£³ÇÏç²î±ð·½Ã棬 £¬³ÇÊеØÇø¶ùͯÇàÉÙÄêµÄ½üÊÓ»¼²¡ÂʸßÓÚÅ©´å£¬ £¬²¢ÇÒ³ÇÊÐÅ®º¢µÄ½üÊÓ»¼²¡ÂÊ£¨32.0%£©¸ßÓÚÄк¢£¨29.4%£©¡£¡£

9F90ECC89568015F6DC8D58308F_E1249DA9_24371

È«Çò¶ùͯÇàÉÙÄê½üÊÓ»¼²¡ÂÊÇéÐÎ

ÖйúÇéÐΣºÑо¿ÍŶӶÔÖйú¶ùͯÇàÉÙÄê½üÊÓÇéÐξÙÐÐÁ˵¥¶ÀÆÊÎö£¬ £¬Í¼3ÏÔʾÁËÖйú¶ùͯÇàÉÙÄêµÄ½üÊÓ»¼²¡ÂÊÇéÐΡ£¡£±¾Ñо¿¹²Éæ¼°1,891,986ÃûÖйú¶ùͯÇàÉÙÄ꣬ £¬ÆäÖÐ4,294,116Ãû»¼ÓнüÊÓ¡£¡£ÕûÌå¶øÑÔ£¬ £¬1990Äêµ½2023ÄêÖйú¶ùͯÇàÉÙÄêµÄ½üÊÓ×Ü»¼²¡ÂÊΪ41.1%¡£¡£²î±ðµØÇø¶ùͯÇàÉÙÄê½üÊÓ»¼²¡ÂÊÓÐËù²î±ð£¬ £¬¶«²¿µØÇø½üÊÓ»¼²¡ÂÊ×î¸ß£¬ £¬Îª46.3%£»£»Æä´ÎÊÇÎ÷²¿£¨37.8%£©ºÍÖв¿µØÇø£¨37.1%£©£»£»ÌØÊâÐÐÕþÇø£¨±¾Ñо¿½öÉæ¼°ÖйúÏã¸ÛºÍÖйų́ÍåµØÇø£©Îª31.3%£»£»¶«±±²¿µØÇøÎª28.0%¡£¡£¹ØÓÚÐÔ±ð²î±ð£¬ £¬ÕûÌåÉÏÅ®º¢µÄ½üÊÓ»¼²¡ÂÊ£¨43.7%£©¸ßÓÚÄк¢£¨39.7%£©£¬ £¬Êý¾ÝÏÔʾÓÈÆäÊǹãÎ÷Å®º¢µÄ½üÊÓ»¼²¡ÂʵִïÁË72.9%£¬ £¬Æä´ÎÊǽ­ËÕÅ®º¢£¨67.4%£©ºÍÉÂÎ÷Å®º¢£¨61.7%£©¡£¡£

δÀ´Ô¤²â£ºÆ¾Ö¤Ô¤²âÆÊÎöЧ¹û£¨±í1£©£¬ £¬2030ÄêÈ«Çò¶ùͯÇàÉÙÄêµÄ½üÊÓ»¼²¡Âʽ«µÖ´ï32.2%£¬ £¬Ô¤¼ÆÓ°Ïì½ü6ÒÚ¶ùͯÇàÉÙÄꣻ£»2040Äê½üÊÓ»¼²¡Âʽ«ÉÏÉýÖÁ36.6%£¬ £¬Ô¤¼ÆÓ°ÏìÁè¼Ý6.6ÒÚ¶ùͯÇàÉÙÄꣻ£»2050Äê½üÊÓ»¼²¡Âʽ«¼ÌÐøÉÏÉýÖÁ39.8%£¬ £¬Ô¤¼ÆÓ°ÏìÁè¼Ý7.4ÒÚ¶ùͯÇàÉÙÄê¡£¡£Ïà½ÏÓÚÄк¢£¬ £¬Å®º¢µÄ½üÊÓ»¼²¡ÂÊÔ¤¼Æ¸ü¸ß£¬ £¬2050Ä꽫´ï42.0%¡£¡£Óë6-12Ëê¶ùͯÏà±È£¬ £¬13-19ËêÇàÉÙÄêµÄ½üÊÓ»¼²¡ÂÊÔ¤¼ÆÏÔןü¸ß£¬ £¬2050Äê¿ÉÄܸߴï52.4%¡£¡£ÓëÅ¹ú¼ÒÏà±È£¬ £¬¿ªÕ¹Öйú¼Ò»ò²»Å¹ú¼ÒµÄ¶ùͯÇàÉÙÄêÔ¤¼ÆÓиü¸ßµÄ½üÊÓ»¼²¡ÂÊ£¬ £¬2050Ä꽫µÖ´ï40.8%£»£»²¢ÇÒÑÇÖÞ½«ÊǽüÊÓ»¼²¡ÂÊ×î¸ßµÄµØÇø£¬ £¬2050ÄêÔ¤¼Æ»¼²¡ÂÊΪ68.8%¡£¡£

±í1 2030-2050ÄêÈ«Çò¶ùͯÇàÉÙÄê½üÊÓÊ¢ÐÐÇ÷ÊÆÔ¤²âÆÊÎö

93A096434EC260546611868768A_AD402E9B_2A8DD

±¾Ñо¿»ã×ÜÁËÈ«Çò¹æÄ£ÄÚ¶ùͯÇàÉÙÄê½üÊÓ»¼²¡ÂʵÄ×îÐÂÖ¤¾Ý£¬ £¬½ÓÄÉϵͳÐÔÒªÁì×ÛºÏÁ˹ØÓÚ½üÊÓ×ÜÌ廼²¡ÂʵÄÏêϸÊý¾Ý£¬ £¬ÆÊÎöÆäÊ¢ÐÐÇ÷ÊÆ²¢¾ÙÐÐδÀ´Ô¤²â¡£¡£Ñо¿Í»³öÁËÈ«Çò²î±ðµØÇø¶ùͯÇàÉÙÄê½üÊÓ»¼²¡ÂʵIJî±ð£¬ £¬²¢ÉîÈëÆÊÎöÁËÐԱ𡢡¢¡¢ÖÖ×åºÍµØÀíλÖõȶàÖÖÒòËØ¶Ô½üÊÓ»¼²¡ÂʵÄÓ°Ïì¡£¡£¸ÃÑо¿ÎªÈ«Çò¶ùͯÇàÉÙÄêÊÓÁ¦¿µ½¡ÏÖ×´ÌṩÁËÖÜÈ«µÄÖ¤¾Ý¡£¡£Ñ­Ö¤Ö¤¾Ý½¨Ò飬 £¬¶ùͯºÍÇàÉÙÄêÓ¦ÔöÌí»§Íâ»î¶¯£¬ £¬ïÔÌ­ÆÁĻʱ¼ä¡£¡£¿£Ë¼Á¿µ½Éç»á¡¢¡¢¡¢¾­¼ÃºÍÎÄ»¯Åä¾°²î±ð£¬ £¬ÔÚ¹«¹²ÎÀÉú¾öÒéÖУ¬ £¬Ïà¹Ø²¿·ÖÓ¦µ±Ô½·¢ÖØÊÓÇøÓò»¯µÄ½üÊÓÔ¤·ÀÕ½ÂÔ£¬ £¬ÒÔÔ½·¢ÓÐÕë¶ÔÐÔºÍÎÞаµÄ·½Ê½Ó¦¶ÔÈÕÒæÑÏÖØµÄÊÓÁ¦¿µ½¡ÌôÕ½¡£¡£

ngµç×ÓÓÎÏ·¹«¹²ÎÀÉúѧԺ²©Ê¿ÉúÁº¾°ºê¡¢¡¢¡¢Ë¶Ê¿ÉúÆÕÓ­çù¡¢¡¢¡¢³Â¼ÑçùΪ±¾ÎĵÄÅäºÏµÚÒ»×÷Õߣ¬ £¬³ÂÑǾü½ÌÊÚΪÂÛÎĵÄΨһͨѶ×÷Õß¡£¡£¸ÃÑо¿Êܵ½¹ú¼Ò×ÔÈ»¿ÆÑ§ÏîÄ¿¡¢¡¢¡¢¹ã¶«Ê¡×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿µÄÖ§³Ö¡£¡£

ÂÛÎÄÁ´½Ó£ºhttps://bjo.bmj.com/content/bjophthalmol/early/2024/08/14/bjo-2024-325427.full.pdf

¡¾ÍøÕ¾µØÍ¼¡¿